Axios AI+ on MSN
AI brings savings to clinical trials: study
Artificial intelligence isn't just speeding up early-stage drug development, it's starting to unlock millions of dollars' worth of new efficiencies in clinical trials on cancer treatments, research ...
Clinical Trials Arena on MSN
Clinical trial success increasingly dependent on strategic collaborations and tech applications
OCT Southern California will focus on streamlining clinical trial operations and technology’s role in gaining deeper trial ...
Austin, United States, Aug. 13, 2026 (GLOBE NEWSWIRE)-- According to SNS Insider, the Generative AI in Clinical Trials Market was valued at USD 245.82 billion in 2025 and is projected to reach USD ...
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi ...
Communication in clinical trials can make or break research and development. Learn how a formal communication plan and a ...
Photys Therapeutics, Inc. ('Photys”), a proximity-based therapeutics company, and Polymed Biopharmaceuticals, Inc. ('Polymed”), a global biotech company focused on creating best-in-class PROTACs ...
Despite this, Walgreens is “doubling down” on its efforts in clinical trials, said Ramita Tandon, the company’s chief clinical trials officer. She previously worked as the chief operating officer of ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most pressing health challenges. By combining advanced ...
73% say the top reason why sponsors are leaving the U.S. is delay and financial cost tied to FDA clinical holds and rework. Surveyed executives cite “current turmoil at the FDA with high turnover” and ...
The Cool Down on MSN
Boston father calls bets on clinical trials 'dark,' as researchers warn of tampering
"They could change any number of variables that could obviously have a direct impact [on] how the trial and the data and the ...
Premium Content is our new free subscription that provides access to deeper analysis, data-led features and exclusive reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results